nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP2E1—alcohol dependence	0.421	1	CbGaD
Ethosuximide—CYP2E1—Disulfiram—alcohol dependence	0.125	0.332	CbGbCtD
Ethosuximide—CYP3A5—Disulfiram—alcohol dependence	0.0969	0.258	CbGbCtD
Ethosuximide—CYP2E1—Citalopram—alcohol dependence	0.0889	0.237	CbGbCtD
Ethosuximide—CYP3A4—Disulfiram—alcohol dependence	0.0378	0.101	CbGbCtD
Ethosuximide—CYP3A4—Citalopram—alcohol dependence	0.0269	0.0718	CbGbCtD
Ethosuximide—Upset stomach—Disulfiram—alcohol dependence	0.00464	0.0404	CcSEcCtD
Ethosuximide—Myopia—Citalopram—alcohol dependence	0.00411	0.0358	CcSEcCtD
Ethosuximide—Libido increased—Acamprosate—alcohol dependence	0.00246	0.0214	CcSEcCtD
Ethosuximide—CYP2E1—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00234	0.0309	CbGpPWpGaD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00226	0.0299	CbGpPWpGaD
Ethosuximide—Paranoia—Acamprosate—alcohol dependence	0.0022	0.0191	CcSEcCtD
Ethosuximide—Upset stomach—Naltrexone—alcohol dependence	0.00216	0.0188	CcSEcCtD
Ethosuximide—Psychotic disorder—Disulfiram—alcohol dependence	0.00216	0.0188	CcSEcCtD
Ethosuximide—Suicidal ideation—Acamprosate—alcohol dependence	0.00214	0.0186	CcSEcCtD
Ethosuximide—Paranoia—Naltrexone—alcohol dependence	0.00208	0.0181	CcSEcCtD
Ethosuximide—Suicidal ideation—Naltrexone—alcohol dependence	0.00202	0.0176	CcSEcCtD
Ethosuximide—CYP3A43—Xenobiotics—CYP2E1—alcohol dependence	0.00199	0.0263	CbGpPWpGaD
Ethosuximide—CYP2E1—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00194	0.0256	CbGpPWpGaD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00187	0.0247	CbGpPWpGaD
Ethosuximide—Abdominal discomfort—Disulfiram—alcohol dependence	0.00183	0.0159	CcSEcCtD
Ethosuximide—Drowsiness—Disulfiram—alcohol dependence	0.0017	0.0148	CcSEcCtD
Ethosuximide—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.0017	0.0224	CbGpPWpGaD
Ethosuximide—CYP2E1—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00165	0.0218	CbGpPWpGaD
Ethosuximide—Disturbance in attention—Naltrexone—alcohol dependence	0.00164	0.0142	CcSEcCtD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00159	0.021	CbGpPWpGaD
Ethosuximide—Cerebration impaired—Citalopram—alcohol dependence	0.00153	0.0133	CcSEcCtD
Ethosuximide—Libido increased—Citalopram—alcohol dependence	0.00148	0.0129	CcSEcCtD
Ethosuximide—CYP2E1—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.0014	0.0185	CbGpPWpGaD
Ethosuximide—Upset stomach—Citalopram—alcohol dependence	0.00137	0.0119	CcSEcCtD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00135	0.0179	CbGpPWpGaD
Ethosuximide—CYP3A43—endocrine gland—alcohol dependence	0.00134	0.0984	CbGeAlD
Ethosuximide—Paranoia—Citalopram—alcohol dependence	0.00132	0.0115	CcSEcCtD
Ethosuximide—Hyperkinesia—Acamprosate—alcohol dependence	0.00131	0.0114	CcSEcCtD
Ethosuximide—Mental disability—Acamprosate—alcohol dependence	0.0013	0.0113	CcSEcCtD
Ethosuximide—CYP3A43—testis—alcohol dependence	0.00128	0.0939	CbGeAlD
Ethosuximide—Suicidal ideation—Citalopram—alcohol dependence	0.00128	0.0112	CcSEcCtD
Ethosuximide—Hyperkinesia—Naltrexone—alcohol dependence	0.00124	0.0108	CcSEcCtD
Ethosuximide—Tongue disorder—Citalopram—alcohol dependence	0.00124	0.0108	CcSEcCtD
Ethosuximide—CYP2E1—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00123	0.0163	CbGpPWpGaD
Ethosuximide—Mental disability—Naltrexone—alcohol dependence	0.00123	0.0107	CcSEcCtD
Ethosuximide—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00123	0.0163	CbGpPWpGaD
Ethosuximide—Euphoric mood—Naltrexone—alcohol dependence	0.00122	0.0106	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Citalopram—alcohol dependence	0.00121	0.0106	CcSEcCtD
Ethosuximide—CYP3A43—liver—alcohol dependence	0.00121	0.0887	CbGeAlD
Ethosuximide—CYP3A43—Biological oxidations—ADH6—alcohol dependence	0.0012	0.0159	CbGpPWpGaD
Ethosuximide—Sleep disorder—Naltrexone—alcohol dependence	0.00119	0.0103	CcSEcCtD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00119	0.0157	CbGpPWpGaD
Ethosuximide—Rash erythematous—Citalopram—alcohol dependence	0.00117	0.0102	CcSEcCtD
Ethosuximide—CYP3A5—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00117	0.0155	CbGpPWpGaD
Ethosuximide—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00109	0.0144	CbGpPWpGaD
Ethosuximide—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.00108	0.00939	CcSEcCtD
Ethosuximide—Psychotic disorder—Acamprosate—alcohol dependence	0.00106	0.00925	CcSEcCtD
Ethosuximide—Lethargy—Naltrexone—alcohol dependence	0.00105	0.00914	CcSEcCtD
Ethosuximide—CACNA1G—digestive system—alcohol dependence	0.00105	0.0768	CbGeAlD
Ethosuximide—Disturbance in attention—Citalopram—alcohol dependence	0.00104	0.00903	CcSEcCtD
Ethosuximide—Aggression—Citalopram—alcohol dependence	0.00102	0.0089	CcSEcCtD
Ethosuximide—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00102	0.00889	CcSEcCtD
Ethosuximide—Psychotic disorder—Naltrexone—alcohol dependence	0.00101	0.00875	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—ADH1A—alcohol dependence	0.000994	0.0131	CbGpPWpGaD
Ethosuximide—Breast disorder—Acamprosate—alcohol dependence	0.000983	0.00856	CcSEcCtD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000983	0.013	CbGpPWpGaD
Ethosuximide—Irritability—Naltrexone—alcohol dependence	0.000982	0.00855	CcSEcCtD
Ethosuximide—Somnolence—Disulfiram—alcohol dependence	0.000965	0.0084	CcSEcCtD
Ethosuximide—Abdominal pain upper—Naltrexone—alcohol dependence	0.00094	0.00818	CcSEcCtD
Ethosuximide—Fatigue—Disulfiram—alcohol dependence	0.000936	0.00815	CcSEcCtD
Ethosuximide—Eosinophilia—Acamprosate—alcohol dependence	0.000931	0.0081	CcSEcCtD
Ethosuximide—Cramp muscle—Naltrexone—alcohol dependence	0.000927	0.00807	CcSEcCtD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00091	0.012	CbGpPWpGaD
Ethosuximide—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.0009	0.0119	CbGpPWpGaD
Ethosuximide—Hiccups—Citalopram—alcohol dependence	0.000898	0.00782	CcSEcCtD
Ethosuximide—CYP2E1—Vitamin A and Carotenoid Metabolism—ADH1A—alcohol dependence	0.000879	0.0116	CbGpPWpGaD
Ethosuximide—CYP2E1—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000866	0.0115	CbGpPWpGaD
Ethosuximide—Abdominal discomfort—Naltrexone—alcohol dependence	0.000853	0.00742	CcSEcCtD
Ethosuximide—Weight decreased—Acamprosate—alcohol dependence	0.000851	0.0074	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—ADH4—alcohol dependence	0.000845	0.0112	CbGpPWpGaD
Ethosuximide—Aplastic anaemia—Citalopram—alcohol dependence	0.000843	0.00734	CcSEcCtD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000836	0.0111	CbGpPWpGaD
Ethosuximide—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000824	0.0109	CbGpPWpGaD
Ethosuximide—CYP3A43—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000813	0.0108	CbGpPWpGaD
Ethosuximide—CACNA1G—nervous system—alcohol dependence	0.000811	0.0594	CbGeAlD
Ethosuximide—Weight decreased—Naltrexone—alcohol dependence	0.000805	0.00701	CcSEcCtD
Ethosuximide—CYP3A7—Xenobiotics—CYP2E1—alcohol dependence	0.0008	0.0106	CbGpPWpGaD
Ethosuximide—Haematuria—Acamprosate—alcohol dependence	0.000799	0.00696	CcSEcCtD
Ethosuximide—Hyperkinesia—Citalopram—alcohol dependence	0.000784	0.00682	CcSEcCtD
Ethosuximide—CACNA1G—central nervous system—alcohol dependence	0.000781	0.0572	CbGeAlD
Ethosuximide—Mental disability—Citalopram—alcohol dependence	0.00078	0.00679	CcSEcCtD
Ethosuximide—Asthenia—Disulfiram—alcohol dependence	0.000779	0.00678	CcSEcCtD
Ethosuximide—Euphoric mood—Citalopram—alcohol dependence	0.000772	0.00672	CcSEcCtD
Ethosuximide—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.000765	0.0101	CbGpPWpGaD
Ethosuximide—CACNA1G—cerebellum—alcohol dependence	0.000763	0.0559	CbGeAlD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000754	0.00997	CbGpPWpGaD
Ethosuximide—Sleep disorder—Citalopram—alcohol dependence	0.000753	0.00656	CcSEcCtD
Ethosuximide—CYP2E1—Vitamin A and Carotenoid Metabolism—ADH4—alcohol dependence	0.000748	0.00989	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—ADH7—alcohol dependence	0.000719	0.0095	CbGpPWpGaD
Ethosuximide—Dizziness—Disulfiram—alcohol dependence	0.000718	0.00625	CcSEcCtD
Ethosuximide—Connective tissue disorder—Naltrexone—alcohol dependence	0.0007	0.00609	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—GGT2—alcohol dependence	0.000689	0.00911	CbGpPWpGaD
Ethosuximide—Rash—Disulfiram—alcohol dependence	0.000684	0.00596	CcSEcCtD
Ethosuximide—Headache—Disulfiram—alcohol dependence	0.00068	0.00592	CcSEcCtD
Ethosuximide—Immune system disorder—Acamprosate—alcohol dependence	0.00068	0.00592	CcSEcCtD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000668	0.00884	CbGpPWpGaD
Ethosuximide—Lethargy—Citalopram—alcohol dependence	0.000665	0.00579	CcSEcCtD
Ethosuximide—Eye disorder—Naltrexone—alcohol dependence	0.000665	0.00579	CcSEcCtD
Ethosuximide—Mental disorder—Acamprosate—alcohol dependence	0.000659	0.00574	CcSEcCtD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000659	0.00871	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000658	0.0087	CbGpPWpGaD
Ethosuximide—Malnutrition—Acamprosate—alcohol dependence	0.000655	0.0057	CcSEcCtD
Ethosuximide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00065	0.0086	CbGpPWpGaD
Ethosuximide—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000647	0.00563	CcSEcCtD
Ethosuximide—Immune system disorder—Naltrexone—alcohol dependence	0.000643	0.0056	CcSEcCtD
Ethosuximide—Mediastinal disorder—Naltrexone—alcohol dependence	0.000642	0.00559	CcSEcCtD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000641	0.00848	CbGpPWpGaD
Ethosuximide—Psychotic disorder—Citalopram—alcohol dependence	0.000637	0.00554	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—ADH1B—alcohol dependence	0.00063	0.00833	CbGpPWpGaD
Ethosuximide—Muscle spasms—Acamprosate—alcohol dependence	0.00063	0.00548	CcSEcCtD
Ethosuximide—Mental disorder—Naltrexone—alcohol dependence	0.000624	0.00543	CcSEcCtD
Ethosuximide—Irritability—Citalopram—alcohol dependence	0.000622	0.00542	CcSEcCtD
Ethosuximide—CACNA1G—brain—alcohol dependence	0.00062	0.0454	CbGeAlD
Ethosuximide—Malnutrition—Naltrexone—alcohol dependence	0.00062	0.0054	CcSEcCtD
Ethosuximide—Ataxia—Citalopram—alcohol dependence	0.000613	0.00534	CcSEcCtD
Ethosuximide—CYP3A7—endocrine gland—alcohol dependence	0.000604	0.0442	CbGeAlD
Ethosuximide—Agitation—Acamprosate—alcohol dependence	0.000602	0.00524	CcSEcCtD
Ethosuximide—Muscle spasms—Naltrexone—alcohol dependence	0.000596	0.00519	CcSEcCtD
Ethosuximide—Abdominal pain upper—Citalopram—alcohol dependence	0.000596	0.00518	CcSEcCtD
Ethosuximide—Breast disorder—Citalopram—alcohol dependence	0.000589	0.00513	CcSEcCtD
Ethosuximide—Cramp muscle—Citalopram—alcohol dependence	0.000587	0.00511	CcSEcCtD
Ethosuximide—Leukopenia—Acamprosate—alcohol dependence	0.000586	0.0051	CcSEcCtD
Ethosuximide—CYP3A5—Xenobiotics—CYP2E1—alcohol dependence	0.000578	0.00764	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.000572	0.00757	CbGpPWpGaD
Ethosuximide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00057	0.00754	CbGpPWpGaD
Ethosuximide—Agitation—Naltrexone—alcohol dependence	0.00057	0.00496	CcSEcCtD
Ethosuximide—Eosinophilia—Citalopram—alcohol dependence	0.000558	0.00486	CcSEcCtD
Ethosuximide—CYP3A5—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000556	0.00735	CbGpPWpGaD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000554	0.00482	CcSEcCtD
Ethosuximide—CYP3A5—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000553	0.00731	CbGpPWpGaD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00055	0.00727	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000546	0.00722	CbGpPWpGaD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000545	0.00721	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000545	0.00721	CbGpPWpGaD
Ethosuximide—CYP3A7—liver—alcohol dependence	0.000544	0.0399	CbGeAlD
Ethosuximide—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000543	0.00719	CbGpPWpGaD
Ethosuximide—Abdominal discomfort—Citalopram—alcohol dependence	0.00054	0.0047	CcSEcCtD
Ethosuximide—Pancytopenia—Citalopram—alcohol dependence	0.000535	0.00466	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000524	0.00456	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—MAOB—alcohol dependence	0.000522	0.00691	CbGpPWpGaD
Ethosuximide—Skin disorder—Acamprosate—alcohol dependence	0.000519	0.00452	CcSEcCtD
Ethosuximide—Weight decreased—Citalopram—alcohol dependence	0.00051	0.00444	CcSEcCtD
Ethosuximide—Anorexia—Acamprosate—alcohol dependence	0.00051	0.00444	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000498	0.00434	CcSEcCtD
Ethosuximide—Nervous system disorder—Naltrexone—alcohol dependence	0.000496	0.00432	CcSEcCtD
Ethosuximide—Skin disorder—Naltrexone—alcohol dependence	0.000491	0.00428	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—ADH6—alcohol dependence	0.000483	0.00639	CbGpPWpGaD
Ethosuximide—Anorexia—Naltrexone—alcohol dependence	0.000482	0.0042	CcSEcCtD
Ethosuximide—Haematuria—Citalopram—alcohol dependence	0.000479	0.00417	CcSEcCtD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000478	0.00632	CbGpPWpGaD
Ethosuximide—Somnolence—Acamprosate—alcohol dependence	0.000475	0.00414	CcSEcCtD
Ethosuximide—Agranulocytosis—Citalopram—alcohol dependence	0.000469	0.00408	CcSEcCtD
Ethosuximide—Decreased appetite—Acamprosate—alcohol dependence	0.000465	0.00405	CcSEcCtD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000464	0.00614	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000463	0.00613	CbGpPWpGaD
Ethosuximide—CYP3A7-CYP3A51P—liver—alcohol dependence	0.000463	0.0339	CbGeAlD
Ethosuximide—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000462	0.00402	CcSEcCtD
Ethosuximide—Somnolence—Naltrexone—alcohol dependence	0.00045	0.00391	CcSEcCtD
Ethosuximide—Urinary tract disorder—Citalopram—alcohol dependence	0.000446	0.00388	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—ALDH2—alcohol dependence	0.000444	0.00587	CbGpPWpGaD
Ethosuximide—Connective tissue disorder—Citalopram—alcohol dependence	0.000443	0.00386	CcSEcCtD
Ethosuximide—Urethral disorder—Citalopram—alcohol dependence	0.000442	0.00385	CcSEcCtD
Ethosuximide—CYP3A43—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000442	0.00584	CbGpPWpGaD
Ethosuximide—Decreased appetite—Naltrexone—alcohol dependence	0.00044	0.00383	CcSEcCtD
Ethosuximide—CYP2E1—Tryptophan metabolism—MAOB—alcohol dependence	0.000438	0.00579	CbGpPWpGaD
Ethosuximide—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000437	0.00381	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000437	0.0038	CcSEcCtD
Ethosuximide—Fatigue—Naltrexone—alcohol dependence	0.000436	0.0038	CcSEcCtD
Ethosuximide—Erythema multiforme—Citalopram—alcohol dependence	0.000427	0.00371	CcSEcCtD
Ethosuximide—Urticaria—Acamprosate—alcohol dependence	0.000425	0.0037	CcSEcCtD
Ethosuximide—Abdominal pain—Acamprosate—alcohol dependence	0.000423	0.00368	CcSEcCtD
Ethosuximide—Eye disorder—Citalopram—alcohol dependence	0.000422	0.00367	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000414	0.0036	CcSEcCtD
Ethosuximide—Immune system disorder—Citalopram—alcohol dependence	0.000407	0.00355	CcSEcCtD
Ethosuximide—Mediastinal disorder—Citalopram—alcohol dependence	0.000407	0.00354	CcSEcCtD
Ethosuximide—Urticaria—Naltrexone—alcohol dependence	0.000402	0.0035	CcSEcCtD
Ethosuximide—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000402	0.00531	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—ADH1A—alcohol dependence	0.0004	0.00529	CbGpPWpGaD
Ethosuximide—Abdominal pain—Naltrexone—alcohol dependence	0.0004	0.00348	CcSEcCtD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000396	0.00524	CbGpPWpGaD
Ethosuximide—Mental disorder—Citalopram—alcohol dependence	0.000395	0.00344	CcSEcCtD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000395	0.00522	CbGpPWpGaD
Ethosuximide—Hypersensitivity—Acamprosate—alcohol dependence	0.000394	0.00343	CcSEcCtD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000394	0.00521	CbGpPWpGaD
Ethosuximide—Malnutrition—Citalopram—alcohol dependence	0.000393	0.00342	CcSEcCtD
Ethosuximide—Asthenia—Acamprosate—alcohol dependence	0.000384	0.00334	CcSEcCtD
Ethosuximide—Muscle spasms—Citalopram—alcohol dependence	0.000378	0.00329	CcSEcCtD
Ethosuximide—Hypersensitivity—Naltrexone—alcohol dependence	0.000373	0.00324	CcSEcCtD
Ethosuximide—CYP2E1—Tryptophan metabolism—ALDH2—alcohol dependence	0.000372	0.00492	CbGpPWpGaD
Ethosuximide—Diarrhoea—Acamprosate—alcohol dependence	0.000366	0.00318	CcSEcCtD
Ethosuximide—Asthenia—Naltrexone—alcohol dependence	0.000363	0.00316	CcSEcCtD
Ethosuximide—Agitation—Citalopram—alcohol dependence	0.000361	0.00314	CcSEcCtD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000358	0.00473	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—CYP2E1—alcohol dependence	0.000355	0.00469	CbGpPWpGaD
Ethosuximide—Dizziness—Acamprosate—alcohol dependence	0.000354	0.00308	CcSEcCtD
Ethosuximide—Leukopenia—Citalopram—alcohol dependence	0.000352	0.00306	CcSEcCtD
Ethosuximide—CYP3A43—Metapathway biotransformation—CYP2E1—alcohol dependence	0.00035	0.00463	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—ADH6—alcohol dependence	0.00035	0.00463	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—ADH6—alcohol dependence	0.000349	0.00462	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000346	0.00458	CbGpPWpGaD
Ethosuximide—Diarrhoea—Naltrexone—alcohol dependence	0.000346	0.00301	CcSEcCtD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000345	0.00457	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—ADH4—alcohol dependence	0.00034	0.0045	CbGpPWpGaD
Ethosuximide—Vomiting—Acamprosate—alcohol dependence	0.00034	0.00296	CcSEcCtD
Ethosuximide—Rash—Acamprosate—alcohol dependence	0.000337	0.00293	CcSEcCtD
Ethosuximide—Dermatitis—Acamprosate—alcohol dependence	0.000337	0.00293	CcSEcCtD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000337	0.00445	CbGpPWpGaD
Ethosuximide—Headache—Acamprosate—alcohol dependence	0.000335	0.00292	CcSEcCtD
Ethosuximide—Dizziness—Naltrexone—alcohol dependence	0.000335	0.00291	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000332	0.00289	CcSEcCtD
Ethosuximide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000332	0.00439	CbGpPWpGaD
Ethosuximide—CYP3A7—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000328	0.00433	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—GGT1—alcohol dependence	0.000326	0.00431	CbGpPWpGaD
Ethosuximide—Vomiting—Naltrexone—alcohol dependence	0.000322	0.0028	CcSEcCtD
Ethosuximide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000321	0.00425	CbGpPWpGaD
Ethosuximide—Rash—Naltrexone—alcohol dependence	0.000319	0.00278	CcSEcCtD
Ethosuximide—Dermatitis—Naltrexone—alcohol dependence	0.000319	0.00277	CcSEcCtD
Ethosuximide—Nausea—Acamprosate—alcohol dependence	0.000318	0.00276	CcSEcCtD
Ethosuximide—Headache—Naltrexone—alcohol dependence	0.000317	0.00276	CcSEcCtD
Ethosuximide—Nervous system disorder—Citalopram—alcohol dependence	0.000314	0.00274	CcSEcCtD
Ethosuximide—Skin disorder—Citalopram—alcohol dependence	0.000311	0.00271	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000306	0.00404	CbGpPWpGaD
Ethosuximide—Anorexia—Citalopram—alcohol dependence	0.000306	0.00266	CcSEcCtD
Ethosuximide—CYP3A5—pancreas—alcohol dependence	0.000301	0.022	CbGeAlD
Ethosuximide—Nausea—Naltrexone—alcohol dependence	0.0003	0.00262	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—MAOA—alcohol dependence	0.000292	0.00386	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—ADH1A—alcohol dependence	0.00029	0.00384	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—ADH7—alcohol dependence	0.000289	0.00383	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—ADH1A—alcohol dependence	0.000289	0.00383	CbGpPWpGaD
Ethosuximide—CYP2E1—cardiovascular system—alcohol dependence	0.000289	0.0212	CbGeAlD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000287	0.00379	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000286	0.00378	CbGpPWpGaD
Ethosuximide—Somnolence—Citalopram—alcohol dependence	0.000285	0.00248	CcSEcCtD
Ethosuximide—Decreased appetite—Citalopram—alcohol dependence	0.000279	0.00243	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—GGT2—alcohol dependence	0.000278	0.00367	CbGpPWpGaD
Ethosuximide—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000277	0.00241	CcSEcCtD
Ethosuximide—Fatigue—Citalopram—alcohol dependence	0.000276	0.00241	CcSEcCtD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000269	0.00356	CbGpPWpGaD
Ethosuximide—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000269	0.00355	CbGpPWpGaD
Ethosuximide—Gastrointestinal pain—Citalopram—alcohol dependence	0.000262	0.00228	CcSEcCtD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—alcohol dependence	0.000261	0.00345	CbGpPWpGaD
Ethosuximide—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000258	0.00342	CbGpPWpGaD
Ethosuximide—CYP3A5—digestive system—alcohol dependence	0.000257	0.0188	CbGeAlD
Ethosuximide—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000257	0.0034	CbGpPWpGaD
Ethosuximide—Urticaria—Citalopram—alcohol dependence	0.000255	0.00222	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—ADH1B—alcohol dependence	0.000254	0.00336	CbGpPWpGaD
Ethosuximide—Abdominal pain—Citalopram—alcohol dependence	0.000253	0.00221	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000253	0.00335	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—ADH4—alcohol dependence	0.000247	0.00326	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—ADH4—alcohol dependence	0.000246	0.00325	CbGpPWpGaD
Ethosuximide—CYP3A5—blood—alcohol dependence	0.000245	0.0179	CbGeAlD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000244	0.00322	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000243	0.00322	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00024	0.00317	CbGpPWpGaD
Ethosuximide—CYP2E1—digestive system—alcohol dependence	0.00024	0.0176	CbGeAlD
Ethosuximide—CACNA1G—Axon guidance—GRIN2B—alcohol dependence	0.000237	0.00314	CbGpPWpGaD
Ethosuximide—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000237	0.00313	CbGpPWpGaD
Ethosuximide—Hypersensitivity—Citalopram—alcohol dependence	0.000236	0.00206	CcSEcCtD
Ethosuximide—Asthenia—Citalopram—alcohol dependence	0.00023	0.002	CcSEcCtD
Ethosuximide—CYP2E1—blood—alcohol dependence	0.000229	0.0167	CbGeAlD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000221	0.00293	CbGpPWpGaD
Ethosuximide—Diarrhoea—Citalopram—alcohol dependence	0.000219	0.00191	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000215	0.00285	CbGpPWpGaD
Ethosuximide—CYP3A5—endocrine gland—alcohol dependence	0.000213	0.0156	CbGeAlD
Ethosuximide—Dizziness—Citalopram—alcohol dependence	0.000212	0.00184	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—MAOB—alcohol dependence	0.00021	0.00278	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—ADH7—alcohol dependence	0.00021	0.00277	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—ADH7—alcohol dependence	0.000209	0.00277	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ADH6—alcohol dependence	0.000205	0.00271	CbGpPWpGaD
Ethosuximide—Vomiting—Citalopram—alcohol dependence	0.000204	0.00177	CcSEcCtD
Ethosuximide—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000203	0.00268	CbGpPWpGaD
Ethosuximide—Rash—Citalopram—alcohol dependence	0.000202	0.00176	CcSEcCtD
Ethosuximide—Dermatitis—Citalopram—alcohol dependence	0.000202	0.00176	CcSEcCtD
Ethosuximide—CYP2E1—Biological oxidations—GGT2—alcohol dependence	0.000201	0.00266	CbGpPWpGaD
Ethosuximide—Headache—Citalopram—alcohol dependence	0.000201	0.00175	CcSEcCtD
Ethosuximide—CYP3A5—Biological oxidations—GGT2—alcohol dependence	0.000201	0.00265	CbGpPWpGaD
Ethosuximide—CYP2E1—endocrine gland—alcohol dependence	0.000198	0.0145	CbGeAlD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000195	0.00257	CbGpPWpGaD
Ethosuximide—CYP3A4—digestive system—alcohol dependence	0.000193	0.0141	CbGeAlD
Ethosuximide—CYP3A5—liver—alcohol dependence	0.000192	0.014	CbGeAlD
Ethosuximide—Nausea—Citalopram—alcohol dependence	0.00019	0.00166	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—POMC—alcohol dependence	0.00019	0.00251	CbGpPWpGaD
Ethosuximide—CYP2E1—testis—alcohol dependence	0.000189	0.0138	CbGeAlD
Ethosuximide—CYP2E1—nervous system—alcohol dependence	0.000186	0.0136	CbGeAlD
Ethosuximide—CYP3A4—blood—alcohol dependence	0.000184	0.0135	CbGeAlD
Ethosuximide—CYP2E1—Biological oxidations—ADH1B—alcohol dependence	0.000184	0.00243	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—ADH1B—alcohol dependence	0.000183	0.00243	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000183	0.00242	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—ALDH2—alcohol dependence	0.000179	0.00236	CbGpPWpGaD
Ethosuximide—CYP2E1—liver—alcohol dependence	0.000179	0.0131	CbGeAlD
Ethosuximide—CYP2E1—central nervous system—alcohol dependence	0.000179	0.0131	CbGeAlD
Ethosuximide—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000178	0.00235	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000176	0.00232	CbGpPWpGaD
Ethosuximide—CYP2E1—cerebellum—alcohol dependence	0.000175	0.0128	CbGeAlD
Ethosuximide—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000173	0.00228	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ADH1A—alcohol dependence	0.00017	0.00225	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—GRIN2B—alcohol dependence	0.000169	0.00224	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000162	0.00215	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000161	0.00212	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00016	0.00212	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00016	0.00212	CbGpPWpGaD
Ethosuximide—CYP3A4—endocrine gland—alcohol dependence	0.000159	0.0117	CbGeAlD
Ethosuximide—CYP2E1—Biological oxidations—MAOB—alcohol dependence	0.000152	0.00201	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—MAOB—alcohol dependence	0.000152	0.00201	CbGpPWpGaD
Ethosuximide—CYP3A4—nervous system—alcohol dependence	0.000149	0.0109	CbGeAlD
Ethosuximide—CYP3A43—Metabolism—ADH4—alcohol dependence	0.000145	0.00191	CbGpPWpGaD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000144	0.00191	CbGpPWpGaD
Ethosuximide—CYP3A4—liver—alcohol dependence	0.000144	0.0105	CbGeAlD
Ethosuximide—CYP3A4—central nervous system—alcohol dependence	0.000144	0.0105	CbGeAlD
Ethosuximide—CYP3A7—Biological oxidations—CYP2E1—alcohol dependence	0.000143	0.00189	CbGpPWpGaD
Ethosuximide—CYP2E1—brain—alcohol dependence	0.000142	0.0104	CbGeAlD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000141	0.00186	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000138	0.00182	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000135	0.00178	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000133	0.00176	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—GGT1—alcohol dependence	0.000131	0.00174	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—ALDH2—alcohol dependence	0.00013	0.00171	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—ALDH2—alcohol dependence	0.000129	0.00171	CbGpPWpGaD
Ethosuximide—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000129	0.0017	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000129	0.0017	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ADH7—alcohol dependence	0.000123	0.00163	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GGT2—alcohol dependence	0.000118	0.00156	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—MAOA—alcohol dependence	0.000118	0.00156	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000114	0.00151	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000113	0.0015	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000112	0.00148	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00011	0.00146	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ADH1B—alcohol dependence	0.000108	0.00143	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000104	0.00138	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000104	0.00138	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP2E1—alcohol dependence	0.000103	0.00137	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000102	0.00135	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—ADH7—alcohol dependence	9.73e-05	0.00129	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GGT1—alcohol dependence	9.51e-05	0.00126	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GGT1—alcohol dependence	9.49e-05	0.00125	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GGT2—alcohol dependence	9.33e-05	0.00123	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	9.04e-05	0.0012	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—MAOB—alcohol dependence	8.93e-05	0.00118	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	8.53e-05	0.00113	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—MAOA—alcohol dependence	8.52e-05	0.00113	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—MAOA—alcohol dependence	8.5e-05	0.00112	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADH6—alcohol dependence	8.26e-05	0.00109	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—POMC—alcohol dependence	7.66e-05	0.00101	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALDH2—alcohol dependence	7.59e-05	0.001	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	7.44e-05	0.000984	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—MAOB—alcohol dependence	7.07e-05	0.000935	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADH1A—alcohol dependence	6.85e-05	0.000905	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GOT2—alcohol dependence	6.46e-05	0.000854	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—EP300—alcohol dependence	6.08e-05	0.000805	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2E1—alcohol dependence	6.07e-05	0.000803	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	6.01e-05	0.000795	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADH6—alcohol dependence	5.99e-05	0.000792	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	5.98e-05	0.00079	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADH6—alcohol dependence	5.97e-05	0.00079	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADH4—alcohol dependence	5.82e-05	0.00077	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GOT1—alcohol dependence	5.57e-05	0.000737	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GGT1—alcohol dependence	5.57e-05	0.000737	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—POMC—alcohol dependence	5.55e-05	0.000734	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—POMC—alcohol dependence	5.54e-05	0.000732	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—MAOA—alcohol dependence	4.99e-05	0.00066	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADH1A—alcohol dependence	4.96e-05	0.000656	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADH7—alcohol dependence	4.95e-05	0.000655	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADH1A—alcohol dependence	4.95e-05	0.000655	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	4.84e-05	0.000641	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	4.8e-05	0.000635	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GGT2—alcohol dependence	4.75e-05	0.000628	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	4.74e-05	0.000627	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GGT1—alcohol dependence	4.41e-05	0.000583	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADH1B—alcohol dependence	4.34e-05	0.000574	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADH4—alcohol dependence	4.22e-05	0.000558	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADH4—alcohol dependence	4.21e-05	0.000557	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—MAOA—alcohol dependence	3.95e-05	0.000523	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MAOB—alcohol dependence	3.6e-05	0.000476	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADH7—alcohol dependence	3.59e-05	0.000474	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADH7—alcohol dependence	3.58e-05	0.000473	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GGT2—alcohol dependence	3.44e-05	0.000455	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GGT2—alcohol dependence	3.43e-05	0.000454	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—POMC—alcohol dependence	3.25e-05	0.00043	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADH1B—alcohol dependence	3.14e-05	0.000416	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADH1B—alcohol dependence	3.14e-05	0.000415	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALDH2—alcohol dependence	3.06e-05	0.000404	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADH6—alcohol dependence	2.78e-05	0.000367	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MAOB—alcohol dependence	2.61e-05	0.000345	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GOT2—alcohol dependence	2.6e-05	0.000344	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MAOB—alcohol dependence	2.6e-05	0.000344	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.57e-05	0.00034	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2E1—alcohol dependence	2.44e-05	0.000323	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADH1A—alcohol dependence	2.3e-05	0.000304	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GGT1—alcohol dependence	2.24e-05	0.000297	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GOT1—alcohol dependence	2.24e-05	0.000297	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALDH2—alcohol dependence	2.22e-05	0.000293	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALDH2—alcohol dependence	2.21e-05	0.000292	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—EP300—alcohol dependence	2.16e-05	0.000285	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MAOA—alcohol dependence	2.01e-05	0.000266	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADH4—alcohol dependence	1.96e-05	0.000259	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GOT2—alcohol dependence	1.88e-05	0.000249	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GOT2—alcohol dependence	1.88e-05	0.000249	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2E1—alcohol dependence	1.77e-05	0.000234	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADH7—alcohol dependence	1.66e-05	0.00022	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GGT1—alcohol dependence	1.63e-05	0.000215	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GOT1—alcohol dependence	1.63e-05	0.000215	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GOT1—alcohol dependence	1.62e-05	0.000215	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GGT1—alcohol dependence	1.62e-05	0.000215	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GGT2—alcohol dependence	1.59e-05	0.000211	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.46e-05	0.000193	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MAOA—alcohol dependence	1.46e-05	0.000193	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MAOA—alcohol dependence	1.45e-05	0.000192	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—POMC—alcohol dependence	1.31e-05	0.000173	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MAOB—alcohol dependence	1.21e-05	0.00016	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.03e-05	0.000136	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—POMC—alcohol dependence	9.49e-06	0.000125	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—POMC—alcohol dependence	9.47e-06	0.000125	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GOT2—alcohol dependence	8.74e-06	0.000116	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—EP300—alcohol dependence	8.69e-06	0.000115	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2E1—alcohol dependence	8.22e-06	0.000109	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GGT1—alcohol dependence	7.54e-06	9.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GOT1—alcohol dependence	7.54e-06	9.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MAOA—alcohol dependence	6.76e-06	8.94e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—EP300—alcohol dependence	6.29e-06	8.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—EP300—alcohol dependence	6.28e-06	8.3e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—POMC—alcohol dependence	4.4e-06	5.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—EP300—alcohol dependence	2.92e-06	3.86e-05	CbGpPWpGaD
